Back to Journals » International Journal of General Medicine » Volume 12

Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges

Authors Mohannak N, Pattison G, Hird K, Needham M

Received 11 September 2019

Accepted for publication 21 November 2019

Published 5 December 2019 Volume 2019:12 Pages 465—474


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser

Nika Mohannak,1 Gemma Pattison,2 Kathryn Hird,1 Merrilee Needham1,3,4

1School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia; 2Department of Speech Pathology, Royal Perth Hospital, Perth, Western Australia, Australia; 3Department of Neurology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia; 4Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia

Correspondence: Merrilee Needham
Institute for Immunology and Infectious Diseases, Murdoch University, Building 390 Discovery Way, Murdoch, WA 6150, Australia
Tel +61 8 9360 1334
Fax +61 8 9360 1380

Abstract: Dysphagia in inclusion body myositis (IBM) is common and associated with increased mortality and morbidity due to aspiration pneumonia, malnutrition and dehydration. There is currently no consensus on treatment of dysphagia in IBM and outcomes are variable depending on timing of intervention, patient preference and available expertise. There is a paucity of research exploring the pathophysiology of dysphagia in IBM and appropriate investigations. Increased knowledge of the aetiopathogenesis is likely to change the approach to treatment as well as improve the quality of life for patients. This review explores the epidemiology and pathophysiology of dysphagia in IBM and the currently available treatment strategies.

Keywords: inflammatory myopathies, swallowing, epidemiology, pathophysiology, treatment, diagnosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]